Why Exhibit?
The Crohn’s & Colitis Congress® convenes the nation’s leading IBD patient organization, the premier gastroenterological professional organization, and the nation’s foremost clinical and research thought leaders. Together, we are at the forefront of comprehensive patient care and revolutionary research and will forge the roadmap toward advancing treatments and cures for IBD.
Even amid the COVID pandemic, the Congress’ fifth year had a robust attendance of 1,200 key professionals from the IBD field and beyond present. Representing insights and practices from the United States and a number of international countries, individuals from a variety of disciplines, including (adult and pediatric) research, surgery, pathology, nutrition, radiology and mental health, convened to focus on methods to catalyze IBD research and accelerate precision medicine, with the goal of answering critical clinical and research questions.
Congress’ seventh year had a robust attendance of over 1,200 key professionals from the IBD field and beyond. Representing insights and practices from the United States and a number of international countries, individuals from a variety of disciplines, including (adult and pediatric) research, surgery, pathology, nutrition, radiology and mental health, convened to focus on methods to catalyze IBD research and accelerate precision medicine, with the goal of answering critical clinical and research questions.
Congress also attracts key audiences, including young and junior investigators, nurses and advanced practice providers, as well as dietitians, who al1l lend unique perspectives crucial in revolutionizing IBD patient care. We invite and encourage all of our partners to demonstrate their commitment to the IBD community by taking part in this unique Congress, where ideas will be shared and networking opportunities afforded within this intimate environment.
Learn more about our
Attendees
Total Attendance
Professional Attendance
Geographic Breakdown
Primary Professional Activity
Areas of Interest
Prescribing Capabilities
Practice Setting
Years in Practice/Research
Exhibit
Opportunities and Benefits
We're excited to offer in-person exhibiting opportunities again, bringing you engagement opportunities with the IBD medical community.
Exhibitor Hours
| Wednesday, January 18 | Exhibitor Move In. |
| Thursday, January 19 | Exhibit Hall Open: 7:15 – 8:30 p.m. |
| Friday, January 20 | Exhibit Hall Open: 7 a.m. – 4:30 p.m. |
| Saturday, January 21 | Exhibit Hall Open: 7 a.m. – 8:30 a.m. Exhibit Hall Move Out starts at 8:30 a.m. |
Marketing
Opportunities
We are committed to creating quality networking and visibility opportunities. With a variety of price points available, you can select that the option that closely aligns with your budget and marketing objectives.
Networking Events
A series of networking events will be available to allow attendees to get to know their peers and colleagues and discover new opportunities for mentorship, partnership and collaboration. Supporters can show their interest, support and dedication to these groups through sponsorship.
- Nurses and Advanced Practice Providers
- Pediatric Providers
- Poster Reception
- Women in IBD
- Young Investigators
- IBD: A to Z – A Clinical Management Overview for Newly Initiated and Experienced Professionals Networking Luncheon
Satellite Symposia
The 2023 Crohn’s & Colitis Congress will host up to eight high-quality, accredited satellite symposia in partnership with medical education companies. Symposia slots will be able to accommodate up to 250 attendees. Up to two concurrent satellite symposia will be available for breakfast (Friday/ Saturday) and lunch (Friday). For additional information, please contact Emma Shaw at eshaw@gastro.org.
Grants
The American Gastroenterological Association Institute, in partnership with Crohn’s & Colitis Foundation, is seeking support for the educational sessions held during the 2023 Crohn’s & Colitis Congress. The Congress brings together IBD professionals across multiple disciplines and merges the best of science and clinical care in a collaborative, comprehensive, multidisciplinary educational setting. The course will be accredited for up to 18 AMA PRA Category 1 Credits™. For additional information, please contact Emma Shaw at eshaw@gastro.org.
We look forward to working with you and ensuring that you have a positive experience sharing your innovations with our attendees.
Interested in learning more or have additional questions, please contact:
Companies #, A-G
ALISA STREETS
Account Manager, Industry Sales and Operations
American Gastroenterological Association
Companies #, H-Z
TESSA AYALA
Senior Account Manager, Industry Sales and Operations
American Gastroenterological Association
